There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.
Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.
A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.
A technique to get more information from the blood of cancer patients than previously possible has been developed.
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing.
Newly-identified cancer cell fingerprints in the blood could one day help doctors diagnose a range of children’s cancers faster and more accurately.
A simple blood test could pinpoint which children are unlikely to respond to treatment for a particularly aggressive form of neuroblastoma
Scientists have developed a new way of looking at how tumours evolve in real-time and develop drug resistance by tracking changes in blood.
A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published in the Lancet Oncology*.